Jordi Xaus

Dr. Xaus holds a degree in Biology (1995) and a master's degree in Immunology (1997) both from the University of Barcelona. He received his doctorate in Biology from the University of Barcelona (1999) in the field of immune response control. He has completed his scientific training with pre and postdoctoral stays at La Jolla Cancer Research Foundation / The Burnham Institute (San Diego, USA, 1996) and at Genentech Inc (San Francisco, USA, 1999-2000). Author of almost a hundred scientific publications and ten patents. Director of six doctoral theses.

He was an Associate Professor of Immunology at the University of Barcelona until 2001, before joining the biotechnology industry. Initially, at Puleva Biotech SA as head of the Immunology Department where, among other projects, he led the discovery and development of the Hereditum® probiotic product line, and years later he became Director of Biomedicine and member of the Board of Directors. In 2007 he joined the biopharmaceutical Palau Pharma SA and in 2012 was nominated CSO. During this period, he participated in the licensing and sale of four Company compounds to third-party pharmaceutical companies.